165 Breast Cancer Control in Iran: National Screening/specialized Breast Unit, Which One is the Urgent Priority?

Abstract

lymphadenectomy was performed at the axillary level III with an average of 17 lymph nodes removed (SD 6.40) and 46% had positive lymph nodes. Most had advanced pathological stage (57% II and 23% III) and 86% were ductal carcinoma infiltrante.O adjuvant treatment with chemotherapy was performed in 59%, the adjuvant radiotherapy performed in 63% and adjuvant hormone therapy in 68%. Patients were followed for a median 61 months (1−94), 16% of deaths occurred in the period, with average survival time of 82 months (95%CI 81−84) (Figure 1). In Kaplan-Meier analysis, the variables that were statistically associated with better overall survival were initial staging (p < 0.000), negative lymph nodes (p < 0.000), tumor size (p < 0.000), number of lymph nodes removed (p = 0.005), adjuvant chemotherapy (p = 0.013) and neo-adjuvant (p < 0.000), adjuvant hormone therapy (p = 0.001), CDI (p = 0.005), conservative surgery (p < 0.000). Conclusions: Overall survival is similar to data found in the literature for staging. The results suggest the need for early diagnosis and treatment.